Development of New Method for Simultaneous Analysis of Piracetam and Levetiracetam in Pharmaceuticals and Biological Fluids: Application in Stability Studies

Table 1

Linearity of proposed method.

(ng/mL)	Piracetam		Levetiracetam
Injected conc.	Recovered	%Recovery	Recovered	%Recovery
20	19.7	98.5	19.82	99.1
50	49.5	99	50.66	101.32
100	100.22	100.22	99.36	99.36
1000	999.1	99.91	998.47	99.847
5000	4978.9	99.578	4912.5	98.25
10000	9997.6	99.976	9993.41	99.9341